HOME › DRUGS › COVID-19 VACCINE (RECOMBINANT, ADJUVANTED)
ACTIVE SUBSTANCE / INN

COVID-19 VACCINE (RECOMBINANT, ADJUVANTED)

Brand name(s): Nuvaxovid, Bimervax, VidPrevtyn Beta
EMA LISTED
WITHDRAWN
AUTHORISED
COVID-19 virus infection
ACTIVE SUBSTANCE
Covid-19 Vaccine (Recombinant, Adjuvanted)
REGULATORS
EMA
SPONSORS / MAH
Sanofi Winthrop Industrie, Hipra Human Health S.L., Sanofi Pasteur
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NuvaxovidSanofi Winthrop IndustrieAuthorised20/12/2021COVID-19 virus infection
BimervaxHipra Human Health S.L.Authorised30/03/2023COVID-19 virus infection
VidPrevtyn BetaSanofi PasteurWithdrawn10/11/2022COVID-19 virus infection

FULL INTELLIGENCE ON COVID-19 VACCINE (RECOMBINANT, ADJUVANTED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →